Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02396602 · ClinicalTrials.gov registry record · NA

miPlan: A Trial of miPlan Intervention vs. Standard of Care

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
225
Enrollment target

NCT02396602: Completed NA study, sponsored by University of Chicago.

NCT02396602 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 225 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02396602, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
225 participants
Enrollment target

Study Summary

Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a randomized controlled trial of the miPlan intervention vs. standard care. The aim of this study is to understand miPlan's impact. The primary outcome is LARC uptake at clinic discharge. The secondary outcomes are contraceptive use at discharge, self-efficacy and decisional balance for highly effective contraception post-app use, contraceptive satisfaction, and intention to continue method use. The research will consist of baseline activities as well as a three-month follow-up call.

Primary Outcome

uptake of the implant or IUD at time of intervention (measured via contraceptive method choice and delivery by checkbox)

Interventions

  • BEHAVIORAL miPlan intervention

Trial Details

FieldValue
Enrollment Target 225 participants
Start Date 2015-02
Est. Completion 2016-08
Phase NA
University of Chicago

796 total trials

What the finished NCT02396602 record still lists

NCT02396602 is an interventional study that assigns participants to a tested intervention. The registered 225 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (84% lower).

The record links to 0 conditions, and to 1 intervention - of which miPlan intervention is the first listed.

NCT02396602 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02396602 about?

NCT02396602 is a clinical study titled "miPlan: A Trial of miPlan Intervention vs. Standard of Care". Using our experience in digital media, behavior theory, client-centered interventions, and family planning, we have prototyped a digital application ("app")-miPlan-to be used in the clinic waiting room prior to a contraceptive visit. The goal of this research is to refine the app and conduct a rando...

What is the current status of trial NCT02396602?

This trial is currently completed. It is a NA study. The enrollment target is 225 participants. The study started on 2015-02. Estimated completion is 2016-08.

What interventions are being tested in trial NCT02396602?

The interventions under investigation include: miPlan intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT02396602?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02396602's enrollment target sits among peer trials

225 472nd of 2000 higher than 1,523 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03955445 · 225 participants · Phase 3

    Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

  • NCT04054310 · 225 participants · NA

    Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

  • NCT04480554 · 225 participants · Phase 2

    Anti-retroviral Therapy, Medications for Opioid Use Disorder, Opioids and HIV Infection - Study 1

  • NCT04888104 · 225 participants

    Prospective, Multicenter, Case-Control Analysis of the VersaTie Posterior Fixation System to Prevent Proximal Junctional Failure in Long Posterior Spinal Fusion Constructs for Adult Patients

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02396602, the US trial registry maintained by the National Library of Medicine. NCT02396602 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.